RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 107 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,612,500 | -38.9% | 1,250,000 | -37.5% | 0.50% | -48.4% |
| Q1 2023 | $2,640,000 | -23.5% | 2,000,000 | -13.0% | 0.96% | -45.7% |
| Q4 2022 | $3,450,000 | +46.2% | 2,300,000 | +15.0% | 1.78% | +28.2% |
| Q3 2022 | $2,360,000 | +4.4% | 2,000,000 | 0.0% | 1.39% | +6.0% |
| Q2 2022 | $2,260,000 | -76.7% | 2,000,000 | -38.5% | 1.31% | -71.6% |
| Q1 2022 | $9,718,000 | -18.5% | 3,250,000 | -27.8% | 4.60% | -6.2% |
| Q4 2021 | $11,925,000 | -53.3% | 4,500,000 | -35.8% | 4.90% | -39.1% |
| Q3 2021 | $25,510,000 | -8.2% | 7,005,000 | +9.5% | 8.06% | +2.4% |
| Q2 2021 | $27,776,000 | -2.7% | 6,400,000 | -23.4% | 7.87% | +34.3% |
| Q1 2021 | $28,557,000 | +10.0% | 8,350,000 | +12.1% | 5.86% | +8.3% |
| Q4 2020 | $25,963,000 | +44.2% | 7,450,000 | -0.7% | 5.41% | -2.5% |
| Q3 2020 | $18,000,000 | +43.6% | 7,500,000 | +9.5% | 5.55% | +58.9% |
| Q2 2020 | $12,536,000 | +44.8% | 6,850,000 | +23.4% | 3.49% | +6.4% |
| Q1 2020 | $8,658,000 | -26.6% | 5,550,000 | -3.5% | 3.28% | +21.8% |
| Q4 2019 | $11,788,000 | +15.1% | 5,750,000 | +5.0% | 2.69% | +0.9% |
| Q3 2019 | $10,238,000 | -27.0% | 5,475,000 | 0.0% | 2.67% | -37.4% |
| Q2 2019 | $14,016,000 | +2.9% | 5,475,000 | +3.3% | 4.26% | -21.2% |
| Q1 2019 | $13,621,000 | +7.7% | 5,300,000 | -3.6% | 5.41% | +4.8% |
| Q4 2018 | $12,650,000 | -13.4% | 5,500,000 | +20.9% | 5.16% | +23.7% |
| Q3 2018 | $14,606,000 | +96.6% | 4,550,000 | +73.3% | 4.17% | +67.7% |
| Q2 2018 | $7,429,000 | – | 2,625,000 | – | 2.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
| Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
| ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
| GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
| NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
| Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.03% |
| XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |